Seminars in Arthroplasty
Volume 19, Issue 3 , Pages 231-236 , September 2008

How I Manage Pain after Total Hip Arthroplasty

  • Mir Ali, MD, PhD

      Affiliations

    • Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA
    • ,
  • Mark W. Pagnano, MD

      Affiliations

    • Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA
    • Corresponding Author InformationAddress reprint requests to Mark W. Pagnano, MD, Mayo College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905
    • ,
  • Terese Horlocker, MD

      Affiliations

    • Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA
    • ,
  • Robert L. Lennon, DO

      Affiliations

    • Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA

References 

  1. Skinner HB. Multimodal acute pain management. Am J Orthop. 2004;33:5–9
  2. Skinner HB, Shintani EY. Results of a multimodal analgesic trial involving patients with total hip or total knee arthroplasty. Am J Orthop. 2004;33:85–92
  3. Wall PD. The prevention of postoperative pain. Pain. 1988;33:289–290
  4. Edwards ND, Wright EM. Continuous low-dose 3-in-1 nerve blockade for postoperative pain relief after total knee replacement. Anesth Analg. 1992;75:265–267
  5. Chelly JE, Gebhard R, Greger J, et al. Regional anesthesia for outpatient orthopedic surgery. Minerva Anestesiol. 2001;67:227–232
  6. Brooks PJ. Pre-emptive analgesia: Performing a painless total knee arthroplasty. Orthopedics. 2003;26:973–974
  7. Reuben SS, Connelly NR. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg. 2000;91:1221–1225
  8. Reuben SS, Fingeroth R, Krushell R, et al. Evaluation of the safety and efficacy of the perioperative administration of rofecoxib for total knee arthroplasty. J Arthroplasty. 2002;17:26–31
  9. Somberg J. Lessons learned from the COX-2 advisory hearings. Am J Ther. 2005;12:105;PMID: 15767826
  10. Stephens JM, Pashos CL, Haider S, et al. Making progress in the management of postoperative pain: A review of the cyclooxygenase 2-specific inhibitors. Pharmacotherapy. 2004;24:1714–1731
  11. Capone ML, et al. J Am Coll Cardiol. 2005;45:1295–1301PMID: 15837265
  12. Gajraj NM. The effect of cyclooxygenase-2 inhibitors on bone healing. Reg Anesth Pain Med. 2003;28:456–465
  13. Wheeler M, Oderda GM, Ashburn MA, et al. Adverse events associated with postoperative opioid analgesia: A systematic review. J Pain. 2002;3:159–180
  14. Reuben SS, Connelly NR, Maciolek H. Postoperative analgesia with controlled-release oxycodone for outpatient anterior cruciate ligament surgery. Anesth Analg. 1999;88:1286–1291
  15. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43:879–923
  16. Hebl JR, Kopp SL, Ali MH, et al. A comprehensive anesthesia protocol that emphasizes peripheral nerve blockade for total knee and total hip arthroplasty. J Bone Joint Surg Am. 2005;87:63–70(suppl 2)
  17. Enneking FK, Chan V, Greger J, et al. Lower extremity peripheral nerve blockade: Essentials of our current understanding. Reg Anesth Pain Med. 2005;30:4–35
  18. In:  Lennon RL,  Horlocker TT editor. Peripheral Blockade for Major Orthopedic Surgery. Florence, KY: Taylor and Francis; 2005;

PII: S1045-4527(08)00040-0

doi: 10.1053/j.sart.2008.08.003

Seminars in Arthroplasty
Volume 19, Issue 3 , Pages 231-236 , September 2008

Article Tools

* Image Usage & Resolution